摘要
Multidrug-resistant tuberculosis (MDR-TB) is defined by bacillary resistant to at least isoniazid and rifampicin in vitro. Although a great diversity of reasons accounting for MDR-TB, poor treatment adherence of patient or inappropriate prescription of physicians are still the major causes. Implementation of DOTS (directly observed therapy, short-course) could decrease incidence of MDR-TB. For MDR-TB, prevention is best strategy. Besides, implantation of DOTS-plus also could increase cure rate. To build efficacious framework system for managing tuberculosis is an important issue to prevent and treat MDR-TB.
原文 | 英語 |
---|---|
頁(從 - 到) | 524-531 |
頁數 | 8 |
期刊 | Journal of Internal Medicine of Taiwan |
卷 | 20 |
發行號 | 6 |
出版狀態 | 已發佈 - 12月 2009 |
ASJC Scopus subject areas
- 內科學